Eli Lilly I5Q-MC-B002
Preventive Treatment of Migraine: Outcomes for Patients in Real-World Healthcare Systems (TRIUMPH)
The purpose of this study is to collect information about treatment patterns, effects, and outcomes in patients with migraine who are switching or initiating a pharmacologic treatment for migraine prevention.
We anticipate that approximately 6000 patients will participate in this study.
Contact Us
Enrollment Information
Contact Kathleen Nagaran Hildebrand at (602) 406-7031 or email DH-MigraineResearch@DignityHealth.org